Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma.

Nature communications·2026
Same author

Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapy.

Molecular therapy. Oncology·2026
Same author

2025 Advancing Cell and Gene Therapies for Cancer post-meeting report.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Matrix composition modulates cancer cell phenotypes and secretions in a blood-brain barrier organ-on-a-chip model: Comparison of collagen and hyaluronic acid.

Biomaterials·2026
Same author

"Targeting NF-κB epigenetic activation and DNA repair deficiency in G34-mutant pediatric diffuse hemispheric glioma with nanoparticles combining PARP inhibition and immune stimulation mediated by CpG dinucleotides".

bioRxiv : the preprint server for biology·2026
Same author

MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapy.

bioRxiv : the preprint server for biology·2026
Same journal

Protocol for ultrasound-guided injection into the murine portal vein to initiate liver metastasis.

STAR protocols·2026
Same journal

Protocol for semi-automatic quantitative bioimaging analysis of synapse loss.

STAR protocols·2026
Same journal

Protocol for integrated ubiquitination analysis of in vitro E3 ligase-DUB regulation and in vivo ubiquitin chain linkage characterization.

STAR protocols·2026
Same journal

Protocol for constructing multi-ancestry polygenic models using S4-Multi.

STAR protocols·2026
Same journal

Protocol for inducing deep vein thrombosis in C57BL/6J mice using the inferior vena cava stenosis model.

STAR protocols·2026
Same journal

Overcoming the challenges of genome-editing essential genes.

STAR protocols·2026
See all related articles

Related Experiment Video

Updated: Sep 21, 2025

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.7K

Murine brain tumor microenvironment immunophenotyping using mass cytometry.

Brandon L McClellan1,2, Mahmoud S Alghamri1,2, Rohit Thalla1,2

  • 1Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI 48109, USA.

STAR Protocols
|May 31, 2022
PubMed
Summary
This summary is machine-generated.

This study details a mass cytometry protocol for analyzing immune cells in mouse glioma. The optimized method aids in understanding the tumor microenvironment in brain cancer research.

Keywords:
AntibodyCancerCell BiologyFlow Cytometry/Mass CytometryImmunologyModel OrganismsNeuroscienceSingle Cell

More Related Videos

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

305
Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples
06:47

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples

Published on: June 29, 2022

2.3K

Related Experiment Videos

Last Updated: Sep 21, 2025

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

9.7K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

305
Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples
06:47

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples

Published on: June 29, 2022

2.3K

Area of Science:

  • Immunology
  • Oncology
  • Neuroscience

Background:

  • The glioma microenvironment harbors diverse immune cells crucial for tumor progression.
  • Understanding immune cell phenotypes is vital for developing effective brain cancer therapies.

Purpose of the Study:

  • To present an optimized mass cytometry protocol for dissecting immune cell phenotypes in mouse glioma models.
  • To provide a comprehensive guide for antibody conjugation, tissue processing, and data analysis.

Main Methods:

  • Utilized a Sleeping Beauty transposon-mediated mouse glioma model.
  • Developed and optimized antibody conjugation and titration strategies.
  • Detailed procedures for brain tumor tissue collection, processing, staining, data acquisition, and analysis.

Main Results:

  • Established a robust mass cytometry protocol applicable to various brain tumor mouse models.
  • Enabled detailed phenotypic analysis of immune cells within the glioma microenvironment.

Conclusions:

  • The presented protocol offers a standardized approach for immune cell profiling in brain tumors.
  • Facilitates in-depth investigation of the immune landscape in glioma research.